STOCK TITAN

Owlet (OWLT) SEC Filings, Jul-Aug 2025

OWLT NYSE

Owlet, Inc. filings document regulatory disclosures for a public pediatric health technology company whose Class A common stock trades on the New York Stock Exchange under OWLT. Recent Form 8-K reports cover operating results, business updates, executive leadership changes, annual meeting matters and stockholder approval of amendments to the company's equity incentive plan.

The filing record also includes disclosures tied to capital structure and financing activity, including preliminary financial information related to an offering and borrowings under an asset-based revolving credit facility. Other material-event filings document shareholder derivative litigation settlement notices, exchange-listed securities, governance matters and exhibits furnished with earnings releases.

Rhea-AI Summary

Owlet entered a privately negotiated Exchange Agreement to swap outstanding warrants for newly issued common stock and related governance commitments. Holders agreed to exchange Series A warrants relating to 7,215,737 shares and Series B warrants relating to 1,799,021 shares for an aggregate of 5,426,429 newly issued shares of Class A common stock. The Exchanges are subject to stockholder approval under NYSE rules and other customary closing conditions and may be terminated if not closed by November 5, 2025. Major participating holders include an entity affiliated with Eclipse (holding ~29% of voting power in Company Voting Securities), Trilogy (~6.7%), the CEO, and a board member, each to receive specified exchanged shares. The Exchanged Shares will be locked up for 180 days post-closing and the company will seek to register resale under the Securities Act, filing a shelf or prospectus supplement within 30 days after closing. The Company used a Black-Scholes model with the 60-day VWAP and realized volatility to value the warrants for the Exchange.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
current report
-
Rhea-AI Summary

Owlet, Inc. delivered revenue of $26.1 million for the quarter and $47.2 million for the six months, both increases versus the prior-year periods, and reported improved gross profit margins. Operating losses narrowed on a six-month basis to $(4.6) million from $(8.0) million a year earlier, reflecting higher sales and controlled operating expenses.

Despite revenue growth and a cash balance of $21.8 million, the company recorded a large non-cash $34.8 million common stock warrant liability adjustment in the quarter that drove a GAAP net loss of $(37.6) million for the three months. Total liabilities rose to $108.0 million and stockholders’ deficit widened to $(59.2) million. Management discloses substantial doubt about the company’s ability to continue as a going concern and relies on existing credit facilities (an ABL line and a term loan) and potential financings. Customer concentration is high: one customer accounted for 64% of quarter revenue and 68% of receivables.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.76%
Tags
quarterly report
-
Form 8-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.08%
Tags
current report
Schedule 13G/A
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.95%
Tags
other

FAQ

How many Owlet (OWLT) SEC filings are available on StockTitan?

StockTitan tracks 64 SEC filings for Owlet (OWLT), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Owlet (OWLT)?

The most recent SEC filing for Owlet (OWLT) was filed on November 16, 2026.